Shenzhen TV Station "Shenzhen Through Train" reported -- Shenzhen (Shenzhen) Health Holding Co., LTD

    Recently, Shenzhen TV's Throughtrain team interviewed Shenzhen's company, just headquartered in Shenzhen, a research-and-development company at present that provides medical device products and services for the global market. Through cutting-edge technology innovation, we provide innovative high-end in vitro diagnostic medical product solutions to improve medical conditions and improve diagnosis and treatment efficiency.

    Lian Zhengxin, General manager, said, "Shenzhen Company is focused on the development, manufacturing and integration services of automated in vitro diagnostic product systems. At present, we have two main platforms in this direction. The first is an immunological based automatic immune cell and histochemical staining platform; Another platform is a fully automatic POCT in vitro diagnostic platform based on immunology. The two platforms focus on the industrial research and development direction, the first is to solve the early cancer screening and auxiliary diagnosis of automatic intelligent upgrade; The second is to solve the early diagnosis of chronic diseases, such as POCT and other rapid bedside detection system, the product can be widely used in grass-roots hospitals and large first-class hospitals; Third, our products focus on the detection of related genetic diseases such as women and children, which improves the early diagnosis of diseases in the general public."

In the future, the company will continue to adhere to the values of "customer-oriented, people-oriented, pragmatic, rigorous, and proactive", increase its research and development efforts in the field of tumor concomitant diagnosis, and make positive contributions to the future of tumor concomitant diagnosis and auxiliary diagnosis! This program was broadcast in the "Shenzhen Through Train" column of Shenzhen Financial Channel on December 8, 2019.